{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:03:48Z","timestamp":1783821828097,"version":"3.55.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00595-016-1337-1","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T06:55:24Z","timestamp":1461912924000},"page":"403-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Liver transplantation for hepatobiliary malignancies: a new era of \u201cTransplant Oncology\u201d has begun"],"prefix":"10.1007","volume":"47","author":[{"given":"Taizo","family":"Hibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Itano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693\u20139.","journal-title":"N Engl J Med"},{"key":"1337_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/org.29245","volume":"10","author":"T Hibi","year":"2014","unstructured":"Hibi T, Shinoda M, Itano O, Kitagawa Y. Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis. 2014;10:241\u20139.","journal-title":"Organogenesis"},{"key":"1337_CR3","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","volume":"13","author":"PA Clavien","year":"2012","unstructured":"Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11\u201322.","journal-title":"Lancet Oncol"},{"key":"1337_CR4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM200105243442112","volume":"344","author":"DC Cronin 2nd","year":"2001","unstructured":"Cronin DC 2nd, Millis JM, Siegler M. Transplantation of liver grafts from living donors into adults\u2013too much, too soon. N Engl J Med. 2001;344:1633\u20137.","journal-title":"N Engl J Med"},{"key":"1337_CR5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2013.07.012","volume":"59","author":"M Rodriguez-Peralvarez","year":"2013","unstructured":"Rodriguez-Peralvarez M, Tsochatzis E, Naveas MC, Pieri G, Garcia-Caparros C, O\u2019Beirne J, et al. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. J Hepatol. 2013;59:1193\u20139.","journal-title":"J Hepatol"},{"key":"1337_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/lt.22441","volume":"18","author":"W Liang","year":"2012","unstructured":"Liang W, Wang D, Ling X, Kao AA, Kong Y, Shang Y, et al. Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl. 2012;18:62\u20139.","journal-title":"Liver Transpl"},{"key":"1337_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/apt.12185","volume":"37","author":"KV Menon","year":"2013","unstructured":"Menon KV, Hakeem AR, Heaton ND. Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther. 2013;37:411\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1337_CR8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/tri.12372","volume":"27","author":"E Cholongitas","year":"2014","unstructured":"Cholongitas E, Mamou C, Rodriguez-Castro KI, Burra P. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int. 2014;27:1039\u201349.","journal-title":"Transpl Int"},{"key":"1337_CR9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/SLA.0000000000000252","volume":"259","author":"T Hibi","year":"2014","unstructured":"Hibi T, Nishida S, Levi DM, Selvaggi G, Tekin A, Fan J, et al. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg. 2014;259:760\u20136.","journal-title":"Ann Surg"},{"key":"1337_CR10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/lt.23689","volume":"19","author":"T Hibi","year":"2013","unstructured":"Hibi T, Nishida S, Levi DM, Sugiyama D, Fukazawa K, Tekin A, et al. Long-term deleterious effects of aortohepatic conduits in primary liver transplantation: proceed with caution. Liver Transpl. 2013;19:916\u201325.","journal-title":"Liver Transpl"},{"key":"1337_CR11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","volume":"143","author":"C Duvoux","year":"2012","unstructured":"Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143:986\u201394 (e3; quiz e14-5).","journal-title":"Gastroenterology"},{"key":"1337_CR12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lt.21368","volume":"14","author":"JI Herrero","year":"2008","unstructured":"Herrero JI, Sangro B, Pardo F, Quiroga J, Inarrairaegui M, Rotellar F, et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl. 2008;14:272\u20138.","journal-title":"Liver Transpl"},{"key":"1337_CR13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.21281","volume":"13","author":"T Ito","year":"2007","unstructured":"Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007;13:1637\u201344.","journal-title":"Liver Transpl"},{"key":"1337_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","volume":"14","author":"SG Lee","year":"2008","unstructured":"Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl. 2008;14:935\u201345.","journal-title":"Liver Transpl"},{"key":"1337_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35\u201343.","journal-title":"Lancet Oncol"},{"key":"1337_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/tri.12274","volume":"27","author":"J Shindoh","year":"2014","unstructured":"Shindoh J, Sugawara Y, Nagata R, Kaneko J, Tamura S, Aoki T, et al. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma. Transpl Int. 2014;27:391\u20138.","journal-title":"Transpl Int"},{"key":"1337_CR17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.21576","volume":"14","author":"M Silva","year":"2008","unstructured":"Silva M, Moya A, Berenguer M, Sanjuan F, Lopez-Andujar R, Pareja E, et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl. 2008;14:1449\u201360.","journal-title":"Liver Transpl"},{"key":"1337_CR18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.tp.0000259015.46798.ec","volume":"83","author":"Y Soejima","year":"2007","unstructured":"Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation. 2007;83:893\u20139.","journal-title":"Transplantation"},{"key":"1337_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","volume":"25","author":"Y Sugawara","year":"2007","unstructured":"Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis. 2007;25:310\u20132.","journal-title":"Dig Dis"},{"key":"1337_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000106908","volume":"25","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis. 2007;25:299\u2013302.","journal-title":"Dig Dis"},{"key":"1337_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27787","volume":"62","author":"C Toso","year":"2015","unstructured":"Toso C, Meeberg G, Hernandez-Alejandro R, Dufour JF, Marotta P, Majno P, et al. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation. Hepatology. 2015;62:158\u201365.","journal-title":"Hepatology"},{"key":"1337_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308513","author":"X Xu","year":"2015","unstructured":"Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2015. doi: 10.1136\/gutjnl-2014-308513 .","journal-title":"Gut."},{"key":"1337_CR23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.surg.2006.11.006","volume":"141","author":"SH Yang","year":"2007","unstructured":"Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, et al. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery. 2007;141:598\u2013609.","journal-title":"Surgery"},{"key":"1337_CR24","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","volume":"7","author":"FY Yao","year":"2007","unstructured":"Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007;7:2587\u201396.","journal-title":"Am J Transplant"},{"key":"1337_CR25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bpg.2014.08.001","volume":"28","author":"S Bhoori","year":"2014","unstructured":"Bhoori S, Mazzaferro V. Current challenges in liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2014;28:867\u201379.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1337_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOT.0000000000000085","volume":"19","author":"Q Lai","year":"2014","unstructured":"Lai Q, Lerut JP. Hepatocellular cancer: how to expand safely inclusion criteria for liver transplantation. Curr Opin Organ Transplant. 2014;19:229\u201334.","journal-title":"Curr Opin Organ Transplant"},{"key":"1337_CR27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/lt.23753","volume":"19","author":"N Mehta","year":"2013","unstructured":"Mehta N, Yao FY. Moving past \u201cOne size (and number) fits all\u201d in the selection of candidates with hepatocellular carcinoma for liver transplantation. Liver Transpl. 2013;19:1055\u20138.","journal-title":"Liver Transpl"},{"key":"1337_CR28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jhep.2010.12.040","volume":"55","author":"S Merani","year":"2011","unstructured":"Merani S, Majno P, Kneteman NM, Berney T, Morel P, Mentha G, et al. The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol. 2011;55:814\u20139.","journal-title":"J Hepatol"},{"key":"1337_CR29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/TP.0b013e31827743d7","volume":"95","author":"TC Dumitra","year":"2013","unstructured":"Dumitra TC, Dumitra S, Metrakos PP, Barkun JS, Chaudhury P, Deschenes M, et al. Pretransplantation alpha-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation. 2013;95:228\u201333.","journal-title":"Transplantation"},{"key":"1337_CR30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/lt.23706","volume":"19","author":"Q Lai","year":"2013","unstructured":"Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, et al. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl. 2013;19:1108\u201318.","journal-title":"Liver Transpl"},{"key":"1337_CR31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-6143.2009.02750.x","volume":"10","author":"E Vibert","year":"2010","unstructured":"Vibert E, Azoulay D, Hoti E, Iacopinelli S, Samuel D, Salloum C, et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant. 2010;10:129\u201337.","journal-title":"Am J Transplant"},{"key":"1337_CR32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.surg.2013.04.056","volume":"154","author":"T Kaido","year":"2013","unstructured":"Kaido T, Ogawa K, Mori A, Fujimoto Y, Ito T, Tomiyama K, et al. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery. 2013;154:1053\u201360.","journal-title":"Surgery"},{"key":"1337_CR33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/TP.0b013e3181943bee","volume":"87","author":"A Taketomi","year":"2009","unstructured":"Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531\u20137.","journal-title":"Transplantation"},{"key":"1337_CR34","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/lt.21334","volume":"13","author":"S Todo","year":"2007","unstructured":"Todo S, Furukawa H, Tada M. Japanese Liver Transplantation Study G. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2007;13:S48\u201354.","journal-title":"Liver Transpl"},{"key":"1337_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00595-015-1142-2","volume":"46","author":"A Hammad","year":"2016","unstructured":"Hammad A, Kaido T, Ogawa K, Fujimoto Y, Uemura T, Mori A, et al. Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B. Surg Today. 2016;46:248\u201354.","journal-title":"Surg Today"},{"key":"1337_CR36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","volume":"220","author":"VG Agopian","year":"2015","unstructured":"Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220:416\u201327.","journal-title":"J Am Coll Surg"},{"key":"1337_CR37","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/TP.0b013e3182187cf0","volume":"91","author":"VR Bertuzzo","year":"2011","unstructured":"Bertuzzo VR, Cescon M, Ravaioli M, Grazi GL, Ercolani G, Del Gaudio M, et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation. 2011;91:1279\u201385.","journal-title":"Transplantation"},{"key":"1337_CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/SLA.0b013e3181a77e59","volume":"250","author":"KJ Halazun","year":"2009","unstructured":"Halazun KJ, Hardy MA, Rana AA, Woodland DC, Luyten EJ, Mahadev S, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250:141\u201351.","journal-title":"Ann Surg"},{"key":"1337_CR39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/hepr.12019","volume":"43","author":"AR Limaye","year":"2013","unstructured":"Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res. 2013;43:757\u201364.","journal-title":"Hepatol Res."},{"key":"1337_CR40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2012.08.017","volume":"58","author":"T Motomura","year":"2013","unstructured":"Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58:58\u201364.","journal-title":"J Hepatol"},{"key":"1337_CR41","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.3748\/wjg.v20.i21.6594","volume":"20","author":"GH Na","year":"2014","unstructured":"Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, et al. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation. World J Gastroenterol. 2014;20:6594\u2013601.","journal-title":"World J Gastroenterol"},{"key":"1337_CR42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/01.TP.0000437426.15890.1d","volume":"97","author":"S Nagai","year":"2014","unstructured":"Nagai S, Abouljoud MS, Kazimi M, Brown KA, Moonka D, Yoshida A. Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2014;97:694\u2013701.","journal-title":"Transplantation"},{"key":"1337_CR43","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/lt.23512","volume":"18","author":"HJ An","year":"2012","unstructured":"An HJ, Jang JW, Bae SH, Choi JY, Yoon SK, Lee MA, et al. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl. 2012;18:1406\u201314.","journal-title":"Liver Transpl"},{"key":"1337_CR44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7150\/ijms.6050","volume":"10","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Zhou L, Gao S, Yang Z, Yao J, Zheng S. Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci. 2013;10:653\u201364.","journal-title":"Int J Med Sci"},{"key":"1337_CR45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2012.06.022","volume":"57","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Stebbing J, Ishizuka M, Khan SA, Wasan HS, North BV, et al. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol. 2012;57:1013\u201320.","journal-title":"J Hepatol"},{"key":"1337_CR46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.12191","volume":"27","author":"Q Lai","year":"2014","unstructured":"Lai Q. Castro Santa E, Rico Juri JM, Pinheiro RS, Lerut J. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. Transpl Int. 2014;27:32\u201341.","journal-title":"Transpl Int"},{"key":"1337_CR47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/lt.23969","volume":"20","author":"I Parisi","year":"2014","unstructured":"Parisi I, Tsochatzis E, Wijewantha H, Rodriguez-Peralvarez M, De Luca L, Manousou P, et al. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria. Liver Transpl. 2014;20:1327\u201335.","journal-title":"Liver Transpl"},{"key":"1337_CR48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jso.23448","volume":"109","author":"KM Sullivan","year":"2014","unstructured":"Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, et al. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014;109:95\u20137.","journal-title":"J Surg Oncol"},{"key":"1337_CR49","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The","year":"2012","unstructured":"European Association For The Study Of The. L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"1337_CR50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ajt.12684","volume":"14","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Clark PJ, Heimbach J, Rosen C, Sanchez W, Watt K, et al. Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size. Am J Transplant. 2014;14:1383\u201390.","journal-title":"Am J Transplant"},{"key":"1337_CR51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2013.04.006","volume":"59","author":"G Otto","year":"2013","unstructured":"Otto G, Schuchmann M, Hoppe-Lotichius M, Heise M, Weinmann A, Hansen T, et al. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? J Hepatol. 2013;59:279\u201384.","journal-title":"J Hepatol"},{"key":"1337_CR52","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/SLA.0000000000001384","volume":"262","author":"VG Agopian","year":"2015","unstructured":"Agopian VG, Morshedi MM, McWilliams J, Harlander-Locke MP, Markovic D, Zarrinpar A, et al. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients. Ann Surg. 2015;262:536\u201345 (discussion 543\u20135).","journal-title":"Ann Surg"},{"key":"1337_CR53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1600-6143.2008.02516.x","volume":"9","author":"A Kornberg","year":"2009","unstructured":"Kornberg A, Freesmeyer M, Barthel E, Jandt K, Katenkamp K, Steenbeck J, et al. 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant. 2009;9:592\u2013600.","journal-title":"Am J Transplant"},{"key":"1337_CR54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00534-009-0167-6","volume":"17","author":"S Lee","year":"2010","unstructured":"Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, et al. Liver transplantation for hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Sci. 2010;17:539\u201347.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1337_CR55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1432-2277.2012.01572.x","volume":"26","author":"SD Lee","year":"2013","unstructured":"Lee SD, Kim SH, Kim YK, Kim C, Kim SK, Han SS, et al. (18)F-FDG-PET\/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. Transpl Int. 2013;26:50\u201360.","journal-title":"Transpl Int"},{"issue":"Suppl 8","key":"1337_CR56","first-page":"S20","volume":"97","author":"KW Lee","year":"2014","unstructured":"Lee KW, Yi NJ, Suh KS. Section\u00a05. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Transplantation. 2014;97(Suppl 8):S20\u20133.","journal-title":"Transplantation"},{"key":"1337_CR57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.21994","volume":"16","author":"O Barakat","year":"2010","unstructured":"Barakat O, Wood RP, Ozaki CF, Ankoma-Sey V, Galati J, Skolkin M, et al. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Liver Transpl. 2010;16:289\u201399.","journal-title":"Liver Transpl"},{"key":"1337_CR58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/radiol.09090927","volume":"255","author":"I Bargellini","year":"2010","unstructured":"Bargellini I, Vignali C, Cioni R, Petruzzi P, Cicorelli A, Campani D, et al. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria\u2013selection parameter for liver transplantation. Radiology. 2010;255:289\u2013300.","journal-title":"Radiology"},{"key":"1337_CR59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00270-012-0458-1","volume":"36","author":"V Bova","year":"2013","unstructured":"Bova V, Miraglia R, Maruzzelli L, Vizzini GB, Luca A. Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies. Cardiovasc Intervent Radiol. 2013;36:433\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1337_CR60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1432-2277.2012.01512.x","volume":"25","author":"O Ciccarelli","year":"2012","unstructured":"Ciccarelli O, Lai Q, Goffette P, Finet P, De Reyck C, Roggen F, et al. Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria. Transpl Int. 2012;25:867\u201375.","journal-title":"Transpl Int"},{"key":"1337_CR61","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/lt.22397","volume":"17","author":"A Cucchetti","year":"2011","unstructured":"Cucchetti A, Cescon M, Bigonzi E, Piscaglia F, Golfieri R, Ercolani G, et al. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy. Liver Transpl. 2011;17:1344\u201354.","journal-title":"Liver Transpl"},{"key":"1337_CR62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/lt.22039","volume":"16","author":"M Giorgio De","year":"2010","unstructured":"De Giorgio M, Vezzoli S, Cohen E, Armellini E, Luca MG, Verga G, et al. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl. 2010;16:503\u201312.","journal-title":"Liver Transpl"},{"key":"1337_CR63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1477-2574.2010.00228.x","volume":"13","author":"DA DuBay","year":"2011","unstructured":"DuBay DA, Sandroussi C, Kachura JR, Ho CS, Beecroft JR, Vollmer CM, et al. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB (Oxford). 2011;13:24\u201332.","journal-title":"HPB (Oxford)"},{"key":"1337_CR64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2036.2009.04167.x","volume":"31","author":"JW Jang","year":"2010","unstructured":"Jang JW, You CR, Kim CW, Bae SH, Yoon SK, Yoo YK, et al. Benefit of downsizing hepatocellular carcinoma in a liver transplant population. Aliment Pharmacol Ther. 2010;31:415\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"1337_CR65","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11605-013-2229-y","volume":"17","author":"J Lei","year":"2013","unstructured":"Lei J, Wang W, Yan L. Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria. J Gastrointest Surg. 2013;17:1440\u20136.","journal-title":"J Gastrointest Surg"},{"key":"1337_CR66","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/liv.12144","volume":"33","author":"E Tsochatzis","year":"2013","unstructured":"Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, et al. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma. Liver Int. 2013;33:944\u20139.","journal-title":"Liver Int"},{"key":"1337_CR67","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1245\/s10434-010-0993-4","volume":"17","author":"A Vitale","year":"2010","unstructured":"Vitale A, D\u2019Amico F, Frigo AC, Grigoletto F, Brolese A, Zanus G, et al. Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. Ann Surg Oncol. 2010;17:2290\u2013302.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR68","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","volume":"61","author":"FY Yao","year":"2015","unstructured":"Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015;61:1968\u201377.","journal-title":"Hepatology"},{"key":"1337_CR69","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jvir.2013.07.024","volume":"24","author":"TJ Green","year":"2013","unstructured":"Green TJ, Rochon PJ, Chang S, Ray CE Jr, Winston H, Ruef R, et al. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. J Vasc Interv Radiol. 2013;24:1613\u201322.","journal-title":"J Vasc Interv Radiol"},{"key":"1337_CR70","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jvir.2013.07.026","volume":"24","author":"S Tohme","year":"2013","unstructured":"Tohme S, Sukato D, Chen HW, Amesur N, Zajko AB, Humar A, et al. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. J Vasc Interv Radiol. 2013;24:1632\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"1337_CR71","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","volume":"9","author":"RJ Lewandowski","year":"2009","unstructured":"Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009;9:1920\u20138.","journal-title":"Am J Transplant"},{"key":"1337_CR72","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2009.12.032","volume":"52","author":"C Toso","year":"2010","unstructured":"Toso C, Mentha G, Kneteman NM, Majno P. The place of downstaging for hepatocellular carcinoma. J Hepatol. 2010;52:930\u20136.","journal-title":"J Hepatol"},{"key":"1337_CR73","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/bjs.7561","volume":"98","author":"AN Gordon-Weeks","year":"2011","unstructured":"Gordon-Weeks AN, Snaith A, Petrinic T, Friend PJ, Burls A, Silva MA. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. Br J Surg. 2011;98:1201\u20138.","journal-title":"Br J Surg"},{"issue":"Suppl 2","key":"1337_CR74","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/lt.22335","volume":"17","author":"FY Yao","year":"2011","unstructured":"Yao FY, Breitenstein S, Broelsch CE, Dufour JF, Sherman M. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver Transpl. 2011;17(Suppl 2):S109\u201316.","journal-title":"Liver Transpl"},{"key":"1337_CR75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2012.09.021","volume":"58","author":"M Cescon","year":"2013","unstructured":"Cescon M, Cucchetti A, Ravaioli M, Pinna AD. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. J Hepatol. 2013;58:609\u201318.","journal-title":"J Hepatol"},{"key":"1337_CR76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cld.2015.01.007","volume":"19","author":"ME Akoad","year":"2015","unstructured":"Akoad ME, Pomfret EA. Surgical resection and liver transplantation for hepatocellular carcinoma. Clin Liver Dis. 2015;19:381\u201399.","journal-title":"Clin Liver Dis"},{"key":"1337_CR77","doi-asserted-by":"crossref","first-page":"425926","DOI":"10.1155\/2015\/425926","volume":"2015","author":"T Kaido","year":"2015","unstructured":"Kaido T, Morita S, Tanaka S, Ogawa K, Mori A, Hatano E, et al. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers. 2015;2015:425926.","journal-title":"Dis Markers"},{"key":"1337_CR78","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.3748\/wjg.v19.i27.4400","volume":"19","author":"JY Lei","year":"2013","unstructured":"Lei JY, Yan LN, Wang WT. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol. 2013;19:4400\u20138.","journal-title":"World J Gastroenterol"},{"key":"1337_CR79","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jhep.2014.01.022","volume":"60","author":"A Vitale","year":"2014","unstructured":"Vitale A, Cucchetti A, Qiao GL, Cescon M, Li J, Ramirez Morales R, et al. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on \u201cnumber of patients needed to transplant\u201d as measure of transplant benefit. J Hepatol. 2014;60:1165\u201371.","journal-title":"J Hepatol"},{"key":"1337_CR80","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1245\/s10434-014-4099-2","volume":"22","author":"A Vitale","year":"2015","unstructured":"Vitale A, Huo TL, Cucchetti A, Lee YH, Volk M, Frigo AC, et al. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: impact of MELD Score. Ann Surg Oncol. 2015;22:1901\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR81","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1245\/s10434-014-3808-1","volume":"21","author":"A Proneth","year":"2014","unstructured":"Proneth A, Zeman F, Schlitt HJ, Schnitzbauer AA. Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol. 2014;21:3096\u2013107.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR82","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1245\/s10434-011-1975-x","volume":"19","author":"CM Ho","year":"2012","unstructured":"Ho CM, Lee PH, Chen CL, Ho MC, Wu YM, Hu RH. Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria. Ann Surg Oncol. 2012;19:826\u201333.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR83","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0b013e31822ca66f","volume":"254","author":"LG Koniaris","year":"2011","unstructured":"Koniaris LG, Levi DM, Pedroso FE, Franceschi D, Tzakis AG, Santamaria-Barria JA, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011;254:527\u201337 (discussion 537\u20138).","journal-title":"Ann Surg"},{"key":"1337_CR84","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1245\/s10434-012-2655-1","volume":"20","author":"G Sapisochin","year":"2013","unstructured":"Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lazaro JL, et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol. 2013;20:1194\u2013202.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00595-015-1211-6","volume":"46","author":"A Soyama","year":"2016","unstructured":"Soyama A, Eguchi S. The current status and future perspectives of organ donation in Japan: learning from the systems in other countries. Surg Today. 2016;46:387\u201392.","journal-title":"Surg Today"},{"key":"1337_CR86","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1053\/j.gastro.2004.09.042","volume":"127","author":"L Kulik","year":"2004","unstructured":"Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004;127:S277\u201382.","journal-title":"Gastroenterology"},{"key":"1337_CR87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.dld.2013.08.137","volume":"46","author":"S Deuffic-Burban","year":"2014","unstructured":"Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, et al. Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach. Dig Liver Dis. 2014;46:157\u201363.","journal-title":"Dig Liver Dis"},{"issue":"974\u201385","key":"1337_CR88","first-page":"e14","volume":"143","author":"S Deuffic-Burban","year":"2012","unstructured":"Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Muhlberger N, et al. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology. 2012;143(974\u201385):e14.","journal-title":"Gastroenterology"},{"key":"1337_CR89","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","volume":"146","author":"JM Pawlotsky","year":"2014","unstructured":"Pawlotsky JM. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology. 2014;146:1176\u201392.","journal-title":"Gastroenterology"},{"key":"1337_CR90","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jhep.2014.08.014","volume":"61","author":"TM Welzel","year":"2014","unstructured":"Welzel TM, Dultz G, Zeuzem S. Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors. J Hepatol. 2014;61:S98\u2013107.","journal-title":"J Hepatol"},{"key":"1337_CR91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","volume":"12","author":"NS Becker","year":"2008","unstructured":"Becker NS, Rodriguez JA, Barshes NR, O\u2019Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg. 2008;12:117\u201322.","journal-title":"J Gastrointest Surg"},{"key":"1337_CR92","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1072-7515(97)00088-4","volume":"185","author":"FA Casavilla","year":"1997","unstructured":"Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185:429\u201336.","journal-title":"J Am Coll Surg"},{"key":"1337_CR93","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","volume":"69","author":"CG Meyer","year":"2000","unstructured":"Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633\u20137.","journal-title":"Transplantation"},{"key":"1337_CR94","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","volume":"239","author":"R Robles","year":"2004","unstructured":"Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265\u201371.","journal-title":"Ann Surg"},{"key":"1337_CR95","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","volume":"7","author":"M Shimoda","year":"2001","unstructured":"Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl. 2001;7:1023\u201333.","journal-title":"Liver Transpl"},{"key":"1337_CR96","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.2011.116","volume":"146","author":"JC Hong","year":"2011","unstructured":"Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011;146:683\u20139.","journal-title":"Arch Surg"},{"key":"1337_CR97","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamcollsurg.2010.12.005","volume":"212","author":"JC Hong","year":"2011","unstructured":"Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, et al. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011;212:514\u201320 (discussion 520\u20131).","journal-title":"J Am Coll Surg"},{"key":"1337_CR98","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","volume":"14","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, Rodriguez de Lope C, Gastaca M, Ortiz de Urbina J, Suarez MA, Santoyo J, et al. \u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant. 2014;14:660\u20137.","journal-title":"Am J Transplant"},{"key":"1337_CR99","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"1337_CR100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1015-9584(09)60149-4","volume":"30","author":"AC Chan","year":"2007","unstructured":"Chan AC, Lo CM, Ng IO, Fan ST. Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg. 2007;30:143\u20136.","journal-title":"Asian J Surg"},{"key":"1337_CR101","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1007\/s10620-010-1402-3","volume":"55","author":"K Maganty","year":"2010","unstructured":"Maganty K, Levi D, Moon J, Bejarano PA, Arosemena L, Tzakis A, et al. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation. Dig Dis Sci. 2010;55:3597\u2013601.","journal-title":"Dig Dis Sci"},{"key":"1337_CR102","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1600-6143.2010.03062.x","volume":"10","author":"C Panjala","year":"2010","unstructured":"Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JH, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010;10:1263\u20137.","journal-title":"Am J Transplant"},{"key":"1337_CR103","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/lt.22307","volume":"17","author":"G Sapisochin","year":"2011","unstructured":"Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011;17:934\u201342.","journal-title":"Liver Transpl"},{"key":"1337_CR104","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jso.23289","volume":"107","author":"RT Groeschl","year":"2013","unstructured":"Groeschl RT, Turaga KK, Gamblin TC. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. J Surg Oncol. 2013;107:608\u201312.","journal-title":"J Surg Oncol"},{"key":"1337_CR105","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","volume":"259","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, Lopez-Andujar R, Palacios F, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg. 2014;259:944\u201352.","journal-title":"Ann Surg"},{"key":"1337_CR106","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.22225","volume":"107","author":"A Mehrabi","year":"2006","unstructured":"Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107:2108\u201321.","journal-title":"Cancer"},{"key":"1337_CR107","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/SLA.0b013e31815c2a70","volume":"246","author":"JP Lerut","year":"2007","unstructured":"Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg. 2007;246:949\u201357 (discussion 957).","journal-title":"Ann Surg"},{"key":"1337_CR108","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11605-007-0247-3","volume":"12","author":"JA Rodriguez","year":"2008","unstructured":"Rodriguez JA, Becker NS, O\u2019Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg. 2008;12:110\u20136.","journal-title":"J Gastrointest Surg"},{"key":"1337_CR109","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1477-2574.2010.00213.x","volume":"12","author":"TE Grotz","year":"2010","unstructured":"Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, et al. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford). 2010;12:546\u201353.","journal-title":"HPB (Oxford)"},{"key":"1337_CR110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/lt.21964","volume":"16","author":"JA Emamaullee","year":"2010","unstructured":"Emamaullee JA, Edgar R, Toso C, Thiesen A, Bain V, Bigam D, et al. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: implications for treatment and surgical management. Liver Transpl. 2010;16:191\u20137.","journal-title":"Liver Transpl"},{"key":"1337_CR111","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1399-3046.2009.01266.x","volume":"14","author":"JJ Guiteau","year":"2010","unstructured":"Guiteau JJ, Cotton RT, Karpen SJ, O\u2019Mahony CA, Goss JA. Pediatric liver transplantation for primary malignant liver tumors with a focus on hepatic epithelioid hemangioendothelioma: the UNOS experience. Pediatr Transplant. 2010;14:326\u201331.","journal-title":"Pediatr Transplant"},{"key":"1337_CR112","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpedsurg.2005.10.091","volume":"41","author":"MT Austin","year":"2006","unstructured":"Austin MT, Leys CM, Feurer ID, Lovvorn HN 3rd, O\u2019Neill JA Jr, Pinson CW, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg. 2006;41:182\u20136.","journal-title":"J Pediatr Surg"},{"key":"1337_CR113","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lt.21586","volume":"14","author":"W Faraj","year":"2008","unstructured":"Faraj W, Dar F, Marangoni G, Bartlett A, Melendez HV, Hadzic D, et al. Liver transplantation for hepatoblastoma. Liver Transpl. 2008;14:1614\u20139.","journal-title":"Liver Transpl"},{"key":"1337_CR114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","volume":"153","author":"RJ Cruz Jr","year":"2013","unstructured":"Cruz RJ Jr, Ranganathan S, Mazariegos G, Soltys K, Nayyar N, Sun Q, et al. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities. Surgery. 2013;153:150\u20139.","journal-title":"Surgery"},{"key":"1337_CR115","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jpedsurg.2008.05.031","volume":"43","author":"M Browne","year":"2008","unstructured":"Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg. 2008;43:1973\u201381.","journal-title":"J Pediatr Surg"},{"key":"1337_CR116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","volume":"42","author":"JB Otte","year":"2004","unstructured":"Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42:74\u201383.","journal-title":"Pediatr Blood Cancer"},{"key":"1337_CR117","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jpedsurg.2012.09.006","volume":"47","author":"T Tajiri","year":"2012","unstructured":"Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, et al. Surgical strategies for unresectable hepatoblastomas. J Pediatr Surg. 2012;47:2194\u20138.","journal-title":"J Pediatr Surg"},{"key":"1337_CR118","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","volume":"36","author":"J Brown","year":"2000","unstructured":"Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma\u2014results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer. 2000;36:1418\u201325.","journal-title":"Eur J Cancer"},{"key":"1337_CR119","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2012.08.001","volume":"215","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Mayo SC, Hyder O, Pawlik TM. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215:820\u201330.","journal-title":"J Am Coll Surg"},{"key":"1337_CR120","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.transproceed.2008.09.050","volume":"40","author":"I Fouzas","year":"2008","unstructured":"Fouzas I, Sotiropoulos GC, Molmenti EP, Beckebaum S, Schmitz KJ, Broelsch CE, et al. \u201cPreemptive\u201d live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report. Transplant Proc. 2008;40:3806\u20137.","journal-title":"Transplant Proc"},{"key":"1337_CR121","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/lt.20132","volume":"10","author":"K Slater","year":"2004","unstructured":"Slater K, Bak TE, Kam I, Wachs ME. Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava. Liver Transpl. 2004;10:555\u20136.","journal-title":"Liver Transpl"},{"key":"1337_CR122","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-6143.2005.01179.x","volume":"6","author":"TL Husted","year":"2006","unstructured":"Husted TL, Neff G, Thomas MJ, Gross TG, Woodle ES, Buell JF. Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant. 2006;6:392\u20137.","journal-title":"Am J Transplant"},{"key":"1337_CR123","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/TP.0b013e318281b902","volume":"95","author":"G Orlando","year":"2013","unstructured":"Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, et al. Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation\u2014the European Liver Transplant Registry experience. Transplantation. 2013;95:872\u20137.","journal-title":"Transplantation"},{"key":"1337_CR124","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/gut.28.6.668","volume":"28","author":"A Forbes","year":"1987","unstructured":"Forbes A, Portmann B, Johnson P, Williams R. Hepatic sarcomas in adults: a review of 25 cases. Gut. 1987;28:668\u201374.","journal-title":"Gut"},{"key":"1337_CR125","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.transproceed.2006.06.057","volume":"38","author":"MH Garcez-Silva","year":"2006","unstructured":"Garcez-Silva MH, Gonzalez AM, Moura RA, Linhares MM, Lanzoni VP, Trivino T. Carcinosarcoma of the liver: a case report. Transplant Proc. 2006;38:1918\u20139.","journal-title":"Transplant Proc"},{"key":"1337_CR126","first-page":"726","volume":"110","author":"I Penn","year":"1991","unstructured":"Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991;110:726\u201334 (discussion 734\u20135).","journal-title":"Surgery"},{"key":"1337_CR127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/lt.23773","volume":"20","author":"A Walther","year":"2014","unstructured":"Walther A, Geller J, Coots A, Towbin A, Nathan J, Alonso M, et al. Multimodal therapy including liver transplantation for hepatic undifferentiated embryonal sarcoma. Liver Transpl. 2014;20:191\u20139.","journal-title":"Liver Transpl"},{"key":"1337_CR128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/j.1536-4801.2006.tb00021.x","volume":"43","author":"LE Chen","year":"2006","unstructured":"Chen LE, Shepherd RW, Nadler ML, Chapman WC, Kotru A, Lowell JA. Liver transplantation and chemotherapy in children with unresectable primary hepatic malignancies: development of a management algorithm. J Pediatr Gastroenterol Nutr. 2006;43:487\u201393.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1337_CR129","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jpedsurg.2008.11.046","volume":"44","author":"H Okajima","year":"2009","unstructured":"Okajima H, Ohya Y, Lee KJ, Yamamoto H, Asonuma K, Nagaoki Y, et al. Management of undifferentiated sarcoma of the liver including living donor liver transplantation as a backup procedure. J Pediatr Surg. 2009;44:e33\u20138.","journal-title":"J Pediatr Surg"},{"key":"1337_CR130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.TP.0000173999.09381.95","volume":"80","author":"AM Cameron","year":"2005","unstructured":"Cameron AM, Truty J, Truell J, Lassman C, Zimmerman MA, Kelly BS Jr, et al. Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy. Transplantation. 2005;80:993\u20136.","journal-title":"Transplantation"},{"key":"1337_CR131","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/MPH.0b013e318212ecb3","volume":"33","author":"D Hanson","year":"2011","unstructured":"Hanson D, Walter AW, Dunn S, Rittenhouse DW, Griffin G. Infantile choriocarcinoma in a neonate with massive liver involvement cured with chemotherapy and liver transplant. J Pediatr Hematol Oncol. 2011;33:e258\u201360.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1337_CR132","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","volume":"6","author":"I Vreede De","year":"2000","unstructured":"De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 2000;6:309\u201316.","journal-title":"Liver Transpl"},{"key":"1337_CR133","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","volume":"2","author":"D Sudan","year":"2002","unstructured":"Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant. 2002;2:774\u20139.","journal-title":"Am J Transplant"},{"key":"1337_CR134","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451\u20138 (discussion 458\u201361).","journal-title":"Ann Surg"},{"key":"1337_CR135","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.25629","volume":"56","author":"S Darwish Murad","year":"2012","unstructured":"Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, et al. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012;56:972\u201381.","journal-title":"Hepatology"},{"key":"1337_CR136","doi-asserted-by":"crossref","unstructured":"Darwish Murad S, Heimbach JK, Gores GJ, Rosen CB, Benson JT, Kim WR. Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl. 2013;19:521\u20138.","DOI":"10.1002\/lt.23630"},{"key":"1337_CR137","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/tri.12640","volume":"28","author":"M Bhat","year":"2015","unstructured":"Bhat M, Hathcock M, Kremers WK, Darwish Murad S, Schmit G, Martenson J, et al. Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol. Transpl Int. 2015;28:1383\u201391.","journal-title":"Transpl Int."},{"key":"1337_CR138","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/ajt.12597","volume":"14","author":"ND Cosgrove","year":"2014","unstructured":"Cosgrove ND, Al-Osaimi AM, Sanoff HK, Morris MM, Read PW, Cox DG, et al. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation. Am J Transplant. 2014;14:466\u201371.","journal-title":"Am J Transplant"},{"key":"1337_CR139","doi-asserted-by":"crossref","unstructured":"Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012;143:88\u201398 (e3; quiz e14).","DOI":"10.1053\/j.gastro.2012.04.008"},{"key":"1337_CR140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.dld.2010.06.005","volume":"42","author":"Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F, Italian Society of G, et al","year":"2010","unstructured":"Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F, Italian Society of G, et al. Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis. 2010;42:831\u20138.","journal-title":"Dig Liver Dis."},{"key":"1337_CR141","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/hpb.12082","volume":"16","author":"S Duignan","year":"2014","unstructured":"Duignan S, Maguire D, Ravichand CS, Geoghegan J, Hoti E, Fennelly D, et al. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience. HPB (Oxford). 2014;16:91\u20138.","journal-title":"HPB (Oxford)"},{"key":"1337_CR142","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129\u201340.","journal-title":"Ann Surg"},{"key":"1337_CR143","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.24227","volume":"53","author":"ML Deoliveira","year":"2011","unstructured":"Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363\u201371.","journal-title":"Hepatology"},{"key":"1337_CR144","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrgastro.2011.67","volume":"8","author":"M Nagino","year":"2011","unstructured":"Nagino M. Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol. 2011;8:252\u20133.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1337_CR145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/bjs.8782","volume":"99","author":"ML DeOliveira","year":"2012","unstructured":"DeOliveira ML, Clavien PA. A common language to describe perihilar cholangiocarcinoma. Br J Surg. 2012;99:885\u20136.","journal-title":"Br J Surg"},{"key":"1337_CR146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2015.01.064","volume":"221","author":"KP Croome","year":"2015","unstructured":"Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? J Am Coll Surg. 2015;221:130\u20139.","journal-title":"J Am Coll Surg"},{"key":"1337_CR147","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1432-2277.2010.01097.x","volume":"23","author":"A Foss","year":"2010","unstructured":"Foss A, Adam R, Dueland S. Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int. 2010;23:679\u201385.","journal-title":"Transpl Int"},{"key":"1337_CR148","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","volume":"257","author":"M Hagness","year":"2013","unstructured":"Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257:800\u20136.","journal-title":"Ann Surg"},{"key":"1337_CR149","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1245\/s10434-013-3449-9","volume":"21","author":"M Hagness","year":"2014","unstructured":"Hagness M, Foss A, Egge TS, Dueland S. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol. 2014;21:1323\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR150","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","volume":"261","author":"S Dueland","year":"2015","unstructured":"Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg. 2015;261:956\u201360.","journal-title":"Ann Surg"},{"key":"1337_CR151","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/SLA.0000000000001165","volume":"262","author":"PD Line","year":"2015","unstructured":"Line PD, Hagness M, Berstad AE, Foss A, Dueland S. A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases: the RAPID Concept. Ann Surg. 2015;262:e5\u20139.","journal-title":"Ann Surg"},{"key":"1337_CR152","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/SLA.0b013e3182908c8d","volume":"257","author":"WC Chapman","year":"2013","unstructured":"Chapman WC. Liver transplantation for unresectable metastases to the liver: a new era in transplantation or a time for caution? Ann Surg. 2013;257:816\u20137.","journal-title":"Ann Surg"},{"key":"1337_CR153","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/SLA.0000000000001269","volume":"262","author":"R Hernandez-Alejandro","year":"2015","unstructured":"Hernandez-Alejandro R, Wall WJ. The RAPID Concept-Novel Idea or a Bridge Too Far? Ann Surg. 2015;262:e10\u20131.","journal-title":"Ann Surg"},{"key":"1337_CR154","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/SLA.0000000000000483","volume":"262","author":"PN Martins","year":"2015","unstructured":"Martins PN, Movahedi B, Bozorgzadeh A. Liver transplantation for unresectable colorectal cancer liver metastases: a paradigm change? Ann Surg. 2015;262:e12.","journal-title":"Ann Surg"},{"key":"1337_CR155","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archsurg.2011.186","volume":"146","author":"R Gedaly","year":"2011","unstructured":"Gedaly R, Daily MF, Davenport D, McHugh PP, Koch A, Angulo P, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg. 2011;146:953\u20138.","journal-title":"Arch Surg"},{"key":"1337_CR156","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","volume":"257","author":"YP Treut Le","year":"2013","unstructured":"Le Treut YP, Gregoire E, Klempnauer J, Belghiti J, Jouve E, Lerut J, et al. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257:807\u201315.","journal-title":"Ann Surg"},{"key":"1337_CR157","doi-asserted-by":"crossref","first-page":"742890","DOI":"10.4061\/2011\/742890","volume":"2011","author":"NT Nguyen","year":"2011","unstructured":"Nguyen NT, Harring TR, Goss JA, O\u2019Mahony CA. Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: the US Experience. Int J Hepatol. 2011;2011:742890.","journal-title":"Int J Hepatol"},{"key":"1337_CR158","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23973","volume":"112","author":"LS Sher","year":"2015","unstructured":"Sher LS, Levi DM, Wecsler JS, Lo M, Petrovic LM, Groshen S, et al. Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables. J Surg Oncol. 2015;112:125\u201332.","journal-title":"J Surg Oncol"},{"key":"1337_CR159","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","volume":"47","author":"V Mazzaferro","year":"2007","unstructured":"Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47:460\u20136.","journal-title":"J Hepatol"},{"key":"1337_CR160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","volume":"95","author":"M Pavel","year":"2012","unstructured":"Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95:157\u201376.","journal-title":"Neuroendocrinology"},{"key":"1337_CR161","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.3748\/wjg.v20.i39.14348","volume":"20","author":"SS Alagusundaramoorthy","year":"2014","unstructured":"Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World J Gastroenterol. 2014;20:14348\u201358.","journal-title":"World J Gastroenterol"},{"key":"1337_CR162","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.28760","volume":"121","author":"A Frilling","year":"2015","unstructured":"Frilling A, Clift AK. Therapeutic strategies for neuroendocrine liver metastases. Cancer. 2015;121:1172\u201386.","journal-title":"Cancer"},{"key":"1337_CR163","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","volume":"13","author":"MH Kulke","year":"2015","unstructured":"Kulke MH, Shah MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, et al. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw. 2015;13:78\u2013108.","journal-title":"J Natl Compr Canc Netw"},{"key":"1337_CR164","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ejca.2004.03.002","volume":"40","author":"E Bompas","year":"2004","unstructured":"Bompas E, Boillot O, Bringuier PP, Dumortier J, Blay JY. Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation. Eur J Cancer. 2004;40:1456\u20137.","journal-title":"Eur J Cancer"},{"key":"1337_CR165","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00042737-200411000-00025","volume":"16","author":"AS Serralta","year":"2004","unstructured":"Serralta AS, Sanjuan FR, Moya AH, Orbis FC, Lopez-Andujar R, Pareja EI, et al. Combined liver transplantation plus imatinib for unresectable metastases of gastrointestinal stromal tumours. Eur J Gastroenterol Hepatol. 2004;16:1237\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1337_CR166","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.TP.0000164141.34293.6B","volume":"80","author":"S Cameron","year":"2005","unstructured":"Cameron S, Ramadori G, Fuzesi L, Sattler B, Gunawan B, Muller D, et al. Successful liver transplantation in two cases of metastatic gastrointestinal stromal tumors. Transplantation. 2005;80:283\u20134.","journal-title":"Transplantation"},{"key":"1337_CR167","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.transproceed.2010.06.016","volume":"42","author":"A Frilling","year":"2010","unstructured":"Frilling A, Malago M, Testa G, Schleyer E, Grabellus F, Kronenberger R, et al. Liver transplantation for metastasized extragastrointestinal stromal tumor: a case report and an overview of literature. Transplant Proc. 2010;42:3843\u20138.","journal-title":"Transplant Proc"},{"key":"1337_CR168","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.transproceed.2011.05.029","volume":"43","author":"AG Dovigo","year":"2011","unstructured":"Dovigo AG, Diaz MB, Gutierrez MG, Selles CF, Grobas JP, Valladares M, et al. Liver transplantation as treatment in a massive metastasis from Gruber-Frantz pancreatic tumor: a case report. Transplant Proc. 2011;43:2272\u20133.","journal-title":"Transplant Proc"},{"key":"1337_CR169","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.transproceed.2008.03.169","volume":"40","author":"B Kocman","year":"2008","unstructured":"Kocman B, Jadrijevic S, Skopljanac A, Mikulic D, Gustin D, Buhin M, et al. Living donor liver transplantation for unresectable liver metastases from solid pseudo-papillary tumor of the pancreas: a case report. Transplant Proc. 2008;40:3787\u201390.","journal-title":"Transplant Proc"},{"key":"1337_CR170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.12659\/AOT.889979","volume":"18","author":"B Lagiewska","year":"2013","unstructured":"Lagiewska B, Pacholczyk M, Lisik W, Cichocki A, Nawrocki G, Trzebicki J, et al. Liver transplantation for nonresectable metastatic solid pseudopapillary pancreatic cancer. Ann Transplant. 2013;18:651\u20133.","journal-title":"Ann Transplant"},{"key":"1337_CR171","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jpedsurg.2007.08.056","volume":"42","author":"W Sumida","year":"2007","unstructured":"Sumida W, Kaneko K, Tainaka T, Ono Y, Kiuchi T, Ando H. Liver transplantation for multiple liver metastases from solid pseudopapillary tumor of the pancreas. J Pediatr Surg. 2007;42:e27\u201331.","journal-title":"J Pediatr Surg"},{"key":"1337_CR172","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-199902150-00027","volume":"67","author":"J Adams","year":"1999","unstructured":"Adams J, Lodge JP, Parker D. Liver transplantation for metastatic hemangiopericytoma associated with hypoglycemia. Transplantation. 1999;67:488\u20139.","journal-title":"Transplantation"},{"key":"1337_CR173","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.transproceed.2015.06.027","volume":"47","author":"K Urata","year":"2015","unstructured":"Urata K, Ikegami T, Nakazawa Y, Ohno Y, Kobayashi A, Mita A, et al. Living-Donor Liver Transplantation for Hepatic Metastasis From Meningeal Hemangiopericytoma: a Case Report. Transplant Proc. 2015;47:2274\u20137.","journal-title":"Transplant Proc"},{"key":"1337_CR174","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhep.2007.07.005","volume":"47","author":"JP Lerut","year":"2007","unstructured":"Lerut JP, Weber M, Orlando G, Dutkowski P. Vascular and rare liver tumors: a good indication for liver transplantation? J Hepatol. 2007;47:466\u201375.","journal-title":"J Hepatol"},{"key":"1337_CR175","first-page":"419","volume":"8","author":"XM Song","year":"2005","unstructured":"Song XM, Zhan WH, Wang JP, Lan P, He XS, Cai SR. et al [Radical resection of gastric or colorectal carcinoma combined with liver transplantation for gastric or colorectal carcinoma with multiple hepatic metastases]. Zhonghua Wei Chang Wai Ke Za Zhi. 2005;8:419\u201321.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"1337_CR176","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","volume":"374","author":"P McCulloch","year":"2009","unstructured":"McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105\u201312.","journal-title":"Lancet"},{"key":"1337_CR177","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2010.30.8650","volume":"29","author":"H Nathan","year":"2011","unstructured":"Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29:619\u201325.","journal-title":"J Clin Oncol"},{"key":"1337_CR178","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1245\/s10434-012-2619-5","volume":"20","author":"H Nathan","year":"2013","unstructured":"Nathan H, Segev DL, Bridges JF, Massie AB, Cameron AM, Hirose K, et al. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol. 2013;20:448\u201356.","journal-title":"Ann Surg Oncol"},{"key":"1337_CR179","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","volume":"100","author":"EK Geissler","year":"2016","unstructured":"Geissler EK, Schnitzbauer AA, Zulke C, Lamby PE, Proneth A, Duvoux C, et al. Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial. Transplantation. 2016;100:116\u201325.","journal-title":"Transplantation"},{"key":"1337_CR180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/TP.0000000000001035","volume":"100","author":"EA Pomfret","year":"2016","unstructured":"Pomfret EA. Killing two birds with one stone: antineoplastic immunosuppression. Transplantation. 2016;100:14\u20135.","journal-title":"Transplantation"},{"key":"1337_CR181","doi-asserted-by":"crossref","unstructured":"Barone C, Koeberle D, Metselaar H, Parisi G, Sansonno D, Spinzi G. Multidisciplinary approach for HCC patients: hepatology for the oncologists. Ann Oncol. 2013;24 Suppl 2:ii15\u201323.","DOI":"10.1093\/annonc\/mdt053"},{"key":"1337_CR182","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.eururo.2010.07.028","volume":"59","author":"G Ciancio","year":"2011","unstructured":"Ciancio G, Gonzalez J, Shirodkar SP, Angulo JC, Soloway MS. Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol. 2011;59:401\u20136.","journal-title":"Eur Urol"},{"key":"1337_CR183","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.eururo.2008.12.038","volume":"55","author":"G Ciancio","year":"2009","unstructured":"Ciancio G, Vaidya A, Shirodkar S, Manoharan M, Hakky T, Soloway M. En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily renal and adrenal, in the left upper quadrant of the abdomen: techniques derived from multivisceral transplantation. Eur Urol. 2009;55:1106\u201311.","journal-title":"Eur Urol"},{"key":"1337_CR184","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/0140-6736(91)93321-Y","volume":"337","author":"L Hannoun","year":"1991","unstructured":"Hannoun L, Panis Y, Balladur P, Delva E, Honiger J, Levy E, et al. Ex-situ in vivo liver surgery. Lancet. 1991;337:1616\u20137.","journal-title":"Lancet"},{"key":"1337_CR185","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1600-6143.2011.03945.x","volume":"12","author":"T Kato","year":"2012","unstructured":"Kato T, Lobritto SJ, Tzakis A, Raveh Y, Sandoval PR, Martinez M, et al. Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant. 2012;12:1323\u20138.","journal-title":"Am J Transplant"},{"key":"1337_CR186","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bjs.1800770107","volume":"77","author":"R Pichlmayr","year":"1990","unstructured":"Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesch P, Bretschneider HJ. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg. 1990;77:21\u20136.","journal-title":"Br J Surg"},{"key":"1337_CR187","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.surg.2012.01.003","volume":"152","author":"AG Tzakis","year":"2012","unstructured":"Tzakis AG, Pararas NB, Tekin A, Gonzalez-Pinto I, Levi D, Nishida S, et al. Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: long-term follow-up. Surgery. 2012;152:82\u20139.","journal-title":"Surgery."},{"key":"1337_CR188","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455\u201365.","journal-title":"N Engl J Med"},{"key":"1337_CR189","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"1337_CR190","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"1337_CR191","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.21035","volume":"43","author":"K Ishiyama","year":"2006","unstructured":"Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology. 2006;43:362\u201372.","journal-title":"Hepatology"},{"key":"1337_CR192","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3727\/096368911X627589","volume":"21","author":"M Ohira","year":"2012","unstructured":"Ohira M, Nishida S, Tryphonopoulos P, Tekin A, Selvaggi G, Moon J, et al. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma. Cell Transplant. 2012;21:1397\u2013406.","journal-title":"Cell Transplant"},{"key":"1337_CR193","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/SLA.0b013e31829c79cf","volume":"258","author":"G Orlando","year":"2013","unstructured":"Orlando G, Soker S, Stratta RJ. Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. Ann Surg. 2013;258:221\u201332.","journal-title":"Ann Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-016-1337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-016-1337-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-016-1337-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-016-1337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T02:52:20Z","timestamp":1718506340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-016-1337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":193,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s00595-016-1337-1","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}